Responses
Clinical/translational cancer immunotherapy
Original research
Incidence of immune checkpoint inhibitor–mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score–matched retrospective study
Compose a Response to This Article
Other responses
No responses have been published for this article.
